×
0 -0.000641299700726831 -0.000641299700726831 -0.00342026507054289 0.00919196237708422 0.00876442924326643 0.0190252244548953 0.00748182984181277
Stockreport

Researchers Behind Spinraza Win Breakthrough Prize [Forbes]

IONIS PHARMACEUTICALS (IONS)  More Company Research Source: Forbes
Last ionis pharmaceuticals earnings: 11/6 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF Frank Bennett of Ionis Pharmaceuticals ©2015 Ken West Photography, Inc. C. Frank Bennett, the head of research at Ionis Pharmaceuticals, and Adrian R. Krainer, the St. Giles Foundation professor at Cold Spring Harbor Laboratory, will share a $3 million Breakthrough Prize for their role in developing Spinraza, a drug against spinal muscular atrophy that is marketed by Ionis and Biogen. The Breakthrough Prizes, an “Oscars of Science” sponsored by Sergey Brin, Priscilla Chan and Mark Zuckerberg, Ma Huateng, Yuri and Julia Milner and Anne Wojcicki, pay out larger amounts than any other scientific award. This year, a total of $22 million will be awarded in a televised awards ceremony on November 4. Breakthrough awards will also be given to Angelika Amon, of the Massachusetts Institute of Technology and Howard Hughes Medical Institute, for research into how having abnormal numbers of chromosomes disrupts cell function; to Xiaowei Zhuang, of Harvard University and Howard Hughes [Read more]

IMPACT SNAPSHOT EVENT TIME: IONS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
IONS alerts
from News Quantified
Opt-in for
IONS alerts

from News Quantified
Opt-in for
IONS alerts

from News Quantified